These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23165329)

  • 1. Dosing of antibiotics in critically ill patients: are we left to wander in the dark?
    Matuszkiewicz-Rowińska J; Małyszko J; Wojtaszek E; Kulicki P
    Pol Arch Med Wewn; 2012; 122(12):630-40. PubMed ID: 23165329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients.
    Roberts JA; Choi GY; Joynt GM; Paul SK; Deans R; Peake S; Cole L; Stephens D; Bellomo R; Turnidge J; Wallis SC; Roberts MS; Roberts DM; Lassig-Smith M; Starr T; Lipman J
    BMC Infect Dis; 2016 Mar; 16():103. PubMed ID: 26932762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic dosing in critically ill patients with acute kidney injury.
    Eyler RF; Mueller BA;
    Nat Rev Nephrol; 2011 Apr; 7(4):226-35. PubMed ID: 21343897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic Dosing in Patients With Acute Kidney Injury: "Enough But Not Too Much".
    Lewis SJ; Mueller BA
    J Intensive Care Med; 2016 Mar; 31(3):164-76. PubMed ID: 25326429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosing of antibiotics in critically ill patients undergoing renal replacement therapy.
    Kielstein JT; Burkhardt O
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2015-9. PubMed ID: 21554216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication dosing in critically ill patients with acute kidney injury treated with renal replacement therapy.
    Scoville BA; Mueller BA
    Am J Kidney Dis; 2013 Mar; 61(3):490-500. PubMed ID: 23127618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock.
    Landersdorfer CB; Nation RL
    Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?
    Jamal JA; Mueller BA; Choi GY; Lipman J; Roberts JA
    Diagn Microbiol Infect Dis; 2015 May; 82(1):92-103. PubMed ID: 25698632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic therapy in sepsis: No next time for a second chance!
    Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M
    J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The management of antibiotic therapy in critically ill patients with AKI: between underdosing and toxicity].
    Canepari G; Inguaggiato P; Besso L
    G Ital Nefrol; 2019 Apr; 36(2):. PubMed ID: 30983169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of renal replacement therapy on pharmacokinetics in critically ill patients.
    Bugge JF
    Best Pract Res Clin Anaesthesiol; 2004 Mar; 18(1):175-87. PubMed ID: 14760881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial dosing in acute renal replacement.
    Fissell WH
    Adv Chronic Kidney Dis; 2013 Jan; 20(1):85-93. PubMed ID: 23265600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of drug dosing guidelines for critically ill patients receiving continuous renal replacement therapy.
    Goldstein SL; Nolin TD
    Clin Pharmacol Ther; 2014 Aug; 96(2):159-61. PubMed ID: 24810205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
    Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
    Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing dosing of antibiotics in critically ill patients.
    Parker SL; Sime FB; Roberts JA
    Curr Opin Infect Dis; 2015 Dec; 28(6):497-504. PubMed ID: 26382000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
    Jamal JA; Udy AA; Lipman J; Roberts JA
    Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic issues for antibiotics in the critically ill patient.
    Roberts JA; Lipman J
    Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using PK/PD to optimize antibiotic dosing for critically ill patients.
    Roberts JA
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2070-9. PubMed ID: 21554211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review.
    Villa G; Di Maggio P; De Gaudio AR; Novelli A; Antoniotti R; Fiaccadori E; Adembri C
    Crit Care; 2016 Nov; 20(1):374. PubMed ID: 27863531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of pharmacists’ antibiotic dosing recommendations for sustained low-efficiency dialysis.
    Mei JP; Ali-Moghaddam A; Mueller BA
    Int J Clin Pharm; 2016 Feb; 38(1):127-34. PubMed ID: 26499505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.